Peihan Xie

Peihan Xie

Auto-generated profile, based on publicly available information

Peihan Xie

First Affiliated Hospital of Sun Yat‐Sen University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
ZZZiwei Zhou
Ziwei Zhou
YHyiquan huang
yiquan huang
XZXiao-dong Zhuang
Xiao-dong Zhuang
YGYue Guo
Yue Guo
PXPeihan Xie
Peihan Xie
LXLiao Xin-xue
Liao Xin-xue
Background: Cardiovascular autonomic neuropathy (CAN) is a severe complication of type 2 diabetes. Significant sex‐related differences have been observed in type 2 diabetes consequences such as mortality. However, the effect of sex on the association between CAN and mortality in patients with type 2 diabetes is currently unknown. Methods and Results: We assessed 7866 participants in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) trial, including 4730 men and 3136 women. CAN was diagnosed using a combination of heart rate variability and QT interval index, which has 3 different definitions. There were 1364 cases of all‐cause mortality and 452 cases of cardiovascular disease mortality during a median follow‐up of 9.7 years. We used multivariable Cox regression models to assess the association between different CAN definitions and mortality. In women, various CAN measures were statistically significant associated with an increased risk of all‐cause mortality (CAN1: hazard ratio [HR], 1.64 [95% CI, 1.28–2.09]; CAN2: HR, 1.58 [95% CI, 1.17–2.15]; CAN3: HR, 1.78 [95% CI, 1.20–2.65]) and mortality (CAN1: HR, 2.25 [95% CI, 1.44–3.52]; CAN 2: HR, 2.22 [95% CI, 1.28–3.87]; CAN3: HR, 3.31 [95% CI, 1.67–6.57]). CAN was not significantly associated with mortality in men. A significant multiplicative interaction of CAN and sex was observed on both mortality outcomes ( P <0.01). Conclusions: Significant sex‐related differences were observed in CAN and its associated mortality. In terms of mortality risk prevention, CAN should be given greater consideration in women with type 2 diabetes.

15 May 2022 in Lupus
Verified
Journal Article
Closed access
WHWei He
Wei He
PXPeihan Xie
Peihan Xie
WLWei Li
Wei Li
FYFengjuan Yao
Fengjuan Yao
YLYanqiu Liu
Yanqiu Liu
DLDonghong Liu
Donghong Liu
Objectives: We aimed to explore the value of two-dimensional speckle tracking echocardiography measurements of the global longitudinal strain (GLS) and left ventricular mechanical dispersion (LVMD) in the assessment of early stage left ventricular systolic dysfunction and heterogeneity of myocardial contraction in patients with lupus nephritis (LN). Methods: Patients with LN and extra-renal systemic lupus erythematosus (SLE) and healthy participants in the control group underwent echocardiography for the traditional measurement of the left ventricular systolic and diastolic function and speckle tracking measurements of the GLS and LVMD. GLS was defined as the average value of the peak strain during systole of the left ventricular 17 segments, and LVMD was defined as the standard deviation. The demographic characteristics including age, sex, and body mass index (BMI) of all the participants were collected. The clinical and laboratory characteristics of the patients with LN were collected. Results: We included 41 healthy control, 37 patients with extra-renal SLE, and 73 patients with LN. There were statistically significant differences in the GLS and LVMD between the extra-renal SLE and LN groups (GLS −19.36% vs. −17.61%, p < 0.001; LVMD 35.62 ms vs 42.96 ms, p<0.001). There was a statistically significant difference in the LVMD between the extral-renal SLE and control groups (35.62ms vs 25.51ms, p 0.05). Multiple regression analyses were conducted in a subset of patients, and 24-hour proteinuria was independently associated with LVMD (β [SE], 0.793 [0.302], p < .05). Conclusions: Patients with LN have more severe myocardial involvement than patients with extra-renal SLE. The asynchrony in myocardial contraction represented by the LVMD can be recognized earlier than that of the overall contractile functional impairment represented by GLS. In patients with LN, the 24-hour proteinuria was associated with LVMD. This indicates that the heterogeneity in the contractile function may be associated with the severity of renal damage.


9 September 2023 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
YHyiquan huang
yiquan huang
PXPeihan Xie
Peihan Xie
SZShaozhao Zhang
Shaozhao Zhang
MLMenghui Liu
Menghui Liu
RHRihua Huang
Rihua Huang
LXLiao Xin-xue
Liao Xin-xue

6 May 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
HZHuimin Zhou
Huimin Zhou
YHyiquan huang
yiquan huang
PXPeihan Xie
Peihan Xie
SZShaozhao Zhang
Shaozhao Zhang
MLMenghui Liu
Menghui Liu
XZXiao-dong Zhuang
Xiao-dong Zhuang
Background: Hyperglycemia is one of the proposed risk factors for cardiac autonomic neuropathy (CAN). CAN is associated with increased cardiovascular and mortality risk. But it remains unclear whether cardiovascular and mortality risk associated with CAN is mitigated by intensive glycemic treatment. Methods and Results: This secondary analysis included 7866 patients from the ACCORDION (Action to Control Cardiovascular Risk in Diabetes Follow‐On) study. CAN was defined using ECG‐derived measures. End points included primary outcome (composite of cardiovascular events) and total deaths. During a median follow‐up of 8.9 years, a total of 1341 cardiovascular events and 1364 all‐cause deaths were ascertained. Compared with standard treatment, intensive treatment reduced risk of primary outcome and total deaths among patients with CAN but not among those without CAN. Compared with absence of CAN, the presence of CAN was associated with increased risk of primary outcome and total deaths in the standard group but not in the intensive group. Significant interactions were found between CAN status and treatment arms on risk of primary outcome and total deaths. Incidence rates per 100 person‐years of primary outcome and total deaths were similar between patients without CAN and those with CAN undergoing intensive treatment. Conclusions: Intensive glycemic treatment mitigates cardiovascular and mortality risk associated with CAN and may serve as an effective way in the management of CAN.

15 January 2021 in Research Square
Verified
Preprint
Open access
PDF file
PXPeihan Xie
Peihan Xie
XZXiaodong Zhuang
Xiaodong Zhuang
MLMenghui Liu
Menghui Liu
SZShaozhao Zhang
Shaozhao Zhang
JLJia Liu
Jia Liu
LXLiao Xin-xue
Liao Xin-xue
Background Echocardiography (echo) is the primary imaging modality for infective endocarditis (IE). However, the recommendations on timing and mode selection for transesophageal echocardiography (TEE) and transthoracic echocardiography (TTE) vary across guidelines, which can be confusing for clinical decision makers. In this case, we aim to appraise the quality of recommendations by appraising the quality of various guidelines.Methods A search of guidelines containing recommendations for the appropriate use of echo in adult IE patients published in English between 2007 and 2019 was conducted. The APPRAISAL OF GUIDELINES FOR RESEARCH & EVALUATION II (AGREE II) instrument was applied independently by two reviewers to assess the integrated quality of the identified guidelines. The recommendations of concern are extracted from related chapters.Results A total of 9 guidelines met the criteria, with AGREE II scores ranging from 36% to 79%, and the domain of “stakeholder involvement” received the lowest score. The most contentious issue is whether a follow-up TEE is mandatory in uncomplicated native valve IE with an initial positive TTE. Conflicting recommendations are presented with a low evidence level based on little evidence.Conclusions In general, the recommendations proposed in the 9 identified guidelines on the appropriate use of echo are satisfying. The guideline quality score can be taken into account by the clinicians when evaluating the recommendations for clinical decisions. Additional studies with high evidence level should be conducted on the most controversial issues of whether a subsequent TEE is mandatory in uncomplicated native valve IE with an initial positive TTE.